Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)
Saudi Arabia
· Delayed Price · Currency is SAR 162.60
+1.50 (0.93%)
Aug 14, 2025, 3:19 PM AST
TADAWUL:4015 Revenue
Jamjoom Pharmaceuticals Factory Company had revenue of 396.22M SAR in the quarter ending June 30, 2025, with 14.60% growth. This brings the company's revenue in the last twelve months to 1.44B, up 16.89% year-over-year. In the year 2024, Jamjoom Pharmaceuticals Factory Company had annual revenue of 1.32B with 19.77% growth.
Revenue (ttm)
1.44B
Revenue Growth
+16.89%
P/S Ratio
7.90
Revenue / Employee
n/a
Employees
n/a
Market Cap
11.38B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Sulaiman Al Habib Medical Services Group Company | 12.65B |
| Mouwasat Medical Services Company | 3.03B |
| Nahdi Medical Company | 9.88B |
| Dallah Healthcare Company | 3.55B |
| Dr. Soliman Abdel Kader Fakeeh Hospital Company | 2.97B |
| National Medical Care Company | 1.48B |
| Almoosa Health Company | 1.31B |
| Al-Dawaa Medical Services Company | 6.70B |